Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Dang

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Hospital Pharmacy|June 16, 2016
PatiromerDennis J Cada, Jessica Dang, Danial E Baker
Cell Insight|April 20, 2026
Podophyllotoxin sensitizes triple-negative breast cancer cells to CD47-targeted immunotherapyJessica Dang, Nuozi Song, Jingkai Zhou, et al.
Science Advances|March 18, 2022
Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapyXu Cao, Jing Chen, Bolei Li, et al.
Blood|February 8, 2022
Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppressionXu Cao, Yingyu Wang, Wencan Zhang, et al.
Nature Communications|April 30, 2025
CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentationSiqi Chen, Yingyu Wang, Jessica Dang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2026
ITGB1 Regulates Triple-Negative Breast Cancer Development by Modulating the Tumor MicroenvironmentNuozi Song, Siqi Chen, Lei Wang, et al.
Research Square|February 24, 2023
Pro-phagocytic function and structural basis of GPR84 signalingXuan Zhang, Yujing Wang, Shreyas Supekar, et al.
Journal for Immunotherapy of Cancer|March 23, 2021
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancerXu Cao, Bolei Li, Jing Chen, et al.
Nature Communications|September 14, 2023
Pro-phagocytic function and structural basis of GPR84 signalingXuan Zhang, Yujing Wang, Shreyas Supekar, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Hospital Pharmacy|June 16, 2016
PatiromerDennis J Cada, Jessica Dang, Danial E Baker
Cell Insight|April 20, 2026
Podophyllotoxin sensitizes triple-negative breast cancer cells to CD47-targeted immunotherapyJessica Dang, Nuozi Song, Jingkai Zhou, et al.
Science Advances|March 18, 2022
Promoting antibody-dependent cellular phagocytosis for effective macrophage-based cancer immunotherapyXu Cao, Jing Chen, Bolei Li, et al.
Blood|February 8, 2022
Targeting macrophages for enhancing CD47 blockade-elicited lymphoma clearance and overcoming tumor-induced immunosuppressionXu Cao, Yingyu Wang, Wencan Zhang, et al.
Nature Communications|April 30, 2025
CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentationSiqi Chen, Yingyu Wang, Jessica Dang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 3, 2026
ITGB1 Regulates Triple-Negative Breast Cancer Development by Modulating the Tumor MicroenvironmentNuozi Song, Siqi Chen, Lei Wang, et al.
Research Square|February 24, 2023
Pro-phagocytic function and structural basis of GPR84 signalingXuan Zhang, Yujing Wang, Shreyas Supekar, et al.
Journal for Immunotherapy of Cancer|March 23, 2021
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancerXu Cao, Bolei Li, Jing Chen, et al.
Nature Communications|September 14, 2023
Pro-phagocytic function and structural basis of GPR84 signalingXuan Zhang, Yujing Wang, Shreyas Supekar, et al.
Pageof 1